Methotrexate-induced systemic vasculitis

Medical and Pediatric Oncology

Volumn 38, Issue 2, 2002, Pages 139-140

  Yoruk, Asim ^a   Cizmecioglu, Filiz ^a   Yukselgungor, Handan ^a   Timur, Cetin ^a   Baydilli, Hikmet ^a   Ozcay, Sevil ^a  

^a NONE   (Turkey)

Author keywords

Childhood cancer; Methotrexate; Systemic vasculitis; Toxicity

Indexed keywords

FOLINIC ACID; METHOTREXATE; METHYLPREDNISOLONE;

ARTICLE; BURKITT LYMPHOMA; CASE REPORT; CHILD; CHILDHOOD CANCER; DRUG INDUCED DISEASE; FEVER; GLOMERULONEPHRITIS; HUMAN; ISCHEMIA; MALE; MESENTERY DISEASE; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; RASH; SYSTEMIC VASCULITIS;

ANTIMETABOLITES, ANTINEOPLASTIC; BURKITT LYMPHOMA; CHILD, PRESCHOOL; HUMANS; MALE; METHOTREXATE; VASCULITIS, HYPERSENSITIVITY;

EID: 0036157343     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/mpo.1293     Document Type: Article

References (10)

1. Methotrexate use in systemic vasculitis
2. Methotrexate: Adverse reactions and major toxicities
3. Methotrexate update
4. Cutaneous side effects of medium dose methotrexate in children with acute lymphoblastic leukemia
5. Severe reversible interstitial pneumonitis induced by low dose methotrexate: Report of a case and review of the literature
6. Methotrexate induced exacerbation of urticarial vasculitis: An unusual adverse reaction
7. Recognition of systemic vasculitis in the acutely ill patient
8. Vasculitis: Diagnosis and therapy
9. Recovery from rheumatoid cerebral vasculitis by low dose methotrexate
10. New concepts in treatment protocols for severe systemic vasculitis